https://www.cureus.com/articles/112673-unresolved-heart-block-in-lyme-carditis-a-case-report

Unresolved Heart Block in Lyme Carditis: A Case Report



Abstract

A man in his thirties presented to the emergency department with a one-day history of syncopal episodes. He was found to have complete heart block and had multiple long and symptomatic pauses in telemetry while in the hospital. The longest pause was measured at 30 seconds. He had frequent occupational exposure to ticks and was found to have positive immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies for Lyme disease. He was immediately started on IV (intravenous) ceftriaxone and isoproterenol infusion for inotropy in anticipation of recovery of atrioventricular (AV) conduction with IV antibiotics. Rapid response was called for multiple symptomatic pauses overnight, the longest one lasting 30 seconds. The patient was taken for urgent temporary transvenous pacemaker placement in the morning. AV conduction failed to improve with IV antibiotics. A permanent pacemaker was placed on day four of hospitalization as his complete heart block failed to resolve with IV antibiotics and the patient could not be weaned from temporary pacemaker support.

A complete heart block is a rare manifestation of Lyme disease and warrants a high index of suspicion when a patient in an endemic area presents with this condition. A majority of patients recover with IV antibiotics, although some patients may need to be put on temporary pacemaker support in the interim. On rare occasions, a permanent pacemaker is necessary.

Atrioventricular conduction may fail to improve with IV antibiotics, and these patients may need early pacemaker support with a transvenous pacemaker in addition to IV ceftriaxone followed by permanent pacemaker placement. Our patient presented with recurrent Lyme disease and had a complete heart block on presentation, which failed to improve with IV antibiotics and required temporary transvenous pacemaker support followed by permanent pacemaker placement.

For more:

There are much sexier, lucrative diseases like zika, COVID, Swine flu, etc. that are cash cows for government bureaucrats in bed with Big Pharma and Big Media.

Please read this important expose on Fauci, the highest paid federal employee who has gotten nearly every single thing wrong about COVID, and who has been at the helm of NIAID for 7 presidencies peddling lies and controlling all government funding for science.  “Dr. Science,” after causing untold damage, is finally stepping down but will hardly fade into the background, and could in fact become even more powerful behind the scenes.

https://childrenshealthdefense.org/defender/fda-autopsy-results-covid-vaccine-deaths-

FDA Refuses to Release Autopsy Results on People Who Died After COVID Vaccines

The U.S. Food and Drug Administration (FDA) said it’s barred from releasing the results of autopsies conducted on people who died after getting COVID-19 vaccines, but a drug safety advocate said the agency could release the autopsies with personal information redacted.

By Zachary Stieber

The U.S. Food and Drug Administration (FDA) is refusing to release the results of autopsies conducted on people who died after getting COVID-19 vaccines.

The FDA says it is barred from releasing medical files, but a drug safety advocate says that it could release the autopsies with personal information redacted.

The refusal was issued to The Epoch Times, which submitted a Freedom of Information Act for all autopsy reported obtained by the FDA concerning any deaths reported to the Vaccine Adverse Event Reporting System (VAERS) following COVID-19 vaccination.

Reports are lodged with the system when a person experiences an adverse event, or a health issue, after receiving a vaccine.

The FDA and other agencies are tasked with investigating the reports. Authorities request and review medical records to vet the reports, including autopsies.

The FDA declined to release any reports, even redacted copies.

The FDA cited federal law, which enables agencies to withhold information if the agency “reasonably foresees that disclosure would harm an interest protected by an exemption,” with the exemption being “personnel and medical files and similar files the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.”

Federal regulations also bar the release of “personnel, medical and similar files the disclosure of which constitutes a clearly unwarranted invasion of personal privacy.”

The Epoch Times has appealed the denial, in addition to the recent denial of results of data analysis of VAERS reports.

‘Easily be redacted’

Kim Witczak, a drug safety advocate who advises the FDA as part of the Psychopharmacologic Drugs Advisory Committee, said that the reports could be released with personal information blacked out.

“The personal information could easily be redacted without losing the potential learnings from [the] autopsy,” Witczak told The Epoch Times via email.

People make the choice to submit autopsy results to the Vaccine Adverse Event Reporting System, Witczak noted.

“If someone submits their experience to VAERS they want and expect to have it investigated by the FDA. This includes autopsy reports,” she said.

Autopsies are examinations of deceased persons performed to determine the cause of death.

“Autopsies can be an important part of postmortem analysis and should be done especially with increased deaths following COVID-19 vaccination,” Witczak said.

FDA responds

An FDA spokesperson noted that deaths following COVID-19 vaccination are rare, citing the number of reports made to VAERS.

As of Sept. 14, 16,516 reports of death following COVID-19 vaccination have been reported. Approximately 616 million doses have been administered in the U.S. through September.

The spokesperson declined to say whether the FDA would ever release the autopsy results but pointed to a paper authored by researchers with the FDA and the Centers for Disease Control and Prevention.

The paper, which has not been peer-reviewed, analyzed the approximately 9,800 reports of death to VAERS following COVID-19 vaccination lodged from Dec. 14, 2020, to Nov. 17, 2021.

Researchers found that reporting rates were lower than the expected all-cause mortality rates.

“Trends in reporting rates reflected known trends in background mortality rates. These findings do not suggest an association between vaccination and overall increased mortality,” the researchers wrote.

The researchers noted that prior studies have found that adverse events reported to VAERS are an undercount of the true number of events.

Reprinted with permission from The Epoch Times

This article was originally published by The Defender — Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.

________________

**UPDATE**

Go here to listen to attorney Aaron Siri on the CDC losing a lawsuit and is forced to turn over 144 Million lines of Injection Data – “Vaccine” adverse events.

V-SAFE Covid Vaccine Injury Data – Shows

  • 7.7% Seek Medical Care After “Vaccination”
  • 25% Have Serious Side Effects
  • Out of the 10 million people who used v-safe, 3,353,110 were hurt

And 6,458,751 health impacts were reported by v-safe users.

Options for health impacts were:

  1. unable to work or attend school;
  2. unable to do your normal daily activities; and/or
  3. get care from a doctor or other healthcare professional  Source

https://thehighwire.com/videos/breaking-news-ican-obtains-cdc-v-safe-data/ 2 Minute Video Here

BREAKING NEWS: ICAN OBTAINS CDC V-SAFE DATA

After 2 lawsuits and months of litigation, ICAN’S legal team, headed by Aaron Siri, has obtained over 144 million rows of health entry data from approximately 10 million users of the CDC’s v-safe app. The public is encouraged to review this data by going to ICAN’s new v-safe Dashboard, available at icandecide.org/v-safe.

Please also watch this interview with former ITV & Sky News Exec Mark Sharman  and Del Big Tree on how mainstream journalism is dead due to its marching in lockstep with government and becoming nothing more than a propaganda machine.

This link shows the latest VAERS data and the mounting list of adverse reactions & death reported after the COVID shots:  https://madisonarealymesupportgroup.com/2020/12/21/warning-3150-injuries-in-1st-week-of-covid-vaccines-among-american-healthcare-workers-pregnant-women-included/

For more:

https://childrenshealthdefense.org/defender/anthony-fauci-net-worth-soar-pandemic

Fauci’s Net Worth Soared to $12.6 Million During Pandemic

OpenTheBooks.com today posted more of the financial disclosures that Dr. Anthony Fauci “didn’t want you to see,” including how Fauci’s net worth jumped to $12.6 million between 2019 through 2021 — an increase of $5 million.

Last night, our auditors at OpenTheBooks.com received Dr. Anthony Fauci’s FY2021 financial disclosures from the National Institutes of Health (NIH).

The documents contain a wealth of previously unknown information. For example, the Fauci household’s net worth now exceeds $12.6 million — up $5 million from 2019 through 2021.

In January 2022, U.S. Sen. Roger Marshall (R.-K.S.) forced open Fauci’s unredacted FY2019 and 2020 financial disclosures. The release followed a heated senate exchange between Fauci and Marshall that concluded with Fauci calling the senator a “moron.”

It was Fauci’s “code red moment” when America’s “top doctor” melted down on national television in the Senate hearing. (When Marshall cited “Forbes,” that was our research on Fauci’s financials published in my then-column at Forbes.)

It’s been a dogfight to open the books on the Fauci finances. For example, our organization has filed four federal lawsuits versus NIH to open the books.

fauci household net worth tracker chart

Today, we post more of the financial disclosures that Fauci didn’t want you to see.

Here’s a summary of our findings from the latest document release:

  • Net worth: The Fauci household disclosed net worth increased from $7.6 million (Jan. 1, 2019) to more than $12.6 million (Dec. 31, 2021).
  • Top paid: Fauci continued to be the most highly compensated federal employee earning $456,000 in 2021 and $480,000 in 2022. Fauci out-earned the president, four-star generals and roughly 4.3 million other federal bureaucrats.
  • Big awards: In 2021, Fauci augmented his government income with nearly $1 million in prizes from non-profit organizations across the world. For example, the Dan David Foundation, based in Israel, awarded $901,400 for “speaking truth to power” and “defending science” during the Trump administration.

During the ongoing pandemic year of 2021, the Fauci’s household income, perks and benefits and unrealized investment gains totaled $2,832,876 — including federal income and benefits of $903,497, outside royalties and travel perks totaling $919,205, and $910,174 in investment gains.  (See link for article and video)

__________________

**Comment**

One things for sure: the plandemic has made certain people very wealthy while causing others to go bankrupt.

Shouldn’t public servants paid with tax dollars be required to fully disclose their financial statements?

Due to Judicial Watch’s efforts, NIH is producing 3,000 pages of line-by-line royalty payments; however, the amount paid to each of the 2,250 individual scientists continues to be redacted.

Fauci and other NIH leaders — received third-party paid royalties; however, the amounts are blanked out, redacted, so the dollars received are unknown, yet Fauci continues to insist his financial records are all out in the open for all to see.

But Fauci et al. are far from alone:

https://www.theblaze.com/news/nearly-100-members-of-congress-could-have-conflict-of-interest-from-financial-trades-analysis-finds

Nearly 100 members of Congress could have conflict of interest from financial trades, analysis finds

A new analysis by The New York Times has found that at least 97 current members of Congress or their immediate families bought or sold stock, bonds, or other financial assets that “intersected with their congressional work.”

Members of Congress are not banned from investing in any company, including those that could be affected by their roles as lawmakers. Numerous congressmen have come under increased scrutiny in recent years for their financial windfalls. Some members have been proven to be such astute traders that analysts have created several exchange-traded funds mirroring the personal portfolios of members of Congress.  (See link for article)

_________________

As long as the pay outs continue, corruption will too. 

https://www.globallymealliance.org/blog/the-most-helpful-thing-in-my-lyme-journey

The article discusses the one thing that has helped me most in my Lyme journey.

Lyme warriors write to me every day to ask what helped me get better. Many of them have been suffering from persistent symptoms for months or years. They find inspiration reading about how well I’m doing, and hope I can give them the magic answer. Most ask, “What medication did you take?” I wish there was a magic answer I could give, but the fact is, no two cases of tick-borne illness are alike. What worked for me might not work for others, and my own protocol has changed many, many times over more than 15 years of treatment.

Because it doesn’t help to give out my ever-changing protocol, I have written about various other therapies and lifestyle changes that have worked in conjunction with medication to get my tick-borne illnesses into remission and keep them there. These include adjunct therapies like integrative manual therapy and neurofeedback, talk therapy, and an anti-inflammatory diet. I’ve learned to pace myself physically and cognitively, have set boundaries around my needs, and have reframed my thinking about living with a chronic illness. My wellness is a result of a complex interplay of many factors, changes, and techniques. I can’t point to any one of them as more helpful than another.

Support

Gala PR Image (15)But if I had to name the one thing that has been the most helpful in my Lyme journey, it would be support. Imagine what happens when someone you know is diagnosed with cancer. That person will suffer physically and emotionally, but they will not do it alone. Friends and family will start websites, fundraisers, and meal trains. They’ll drive the patient to appointments, sit with them afterwards, do their dishes, help with their kids, water their plants. They’ll send cards and flowers, and call often to check in. They will never say to the patient, “Aren’t you over that yet?” or, “Maybe you don’t really have cancer. Maybe it’s just all in your head.” The patient will be enveloped in support that will allow them to focus solely on getting well.

If that same person had Lyme disease instead of cancer, the response might be very different. Some Lyme warriors have excellent support networks, but too many are misunderstood by family, friends, and doctors alike. Not only do these patients have to fight to get well, but they also have to fight to be believed. They spend energy they don’t have trying to convince others of their suffering. They often don’t get the help they need, whether it’s running an errand, appealing an insurance denial, or just having a comfortable shoulder to cry on. Lyme patients need and deserve the same outpouring of support that patients with better-known and less-controversial illnesses count on.

When I first got sick with mono that slipped into chronic Epstein-Barr virus, I struggled to get a diagnosis. Two years later, I was also diagnosed with underlying tick-borne infections. I thought I finally had the magic answer—an infection that could be treated! Little did I know what I was up against. The subsequent years were an uphill battle not just for wellness, but for validation. I had to find the right medical support, and figure out who I could talk to that would stand beside me on the journey. I had to learn to brush off the naysayers and to trust that I knew my body best.

My friends supported me unconditionally, even if they didn’t fully understand my illnesses. They started email support chains for me. They came to visit. They called and sent cards. My family had a harder time understanding tick-borne illnesses, and chronic illness in general, at the beginning. They wondered when I would get well, how much longer it would take, whether I had something else entirely. It wasn’t easy for them to have me under their roof as an adult, and it wasn’t easy for any of us to communicate our feelings and needs. Over time, their Lyme literacy—and their understanding—has improved dramatically. We’ve all come to understand what it means for a family member to live with a chronic illness, which has made all the difference in my healing journey.

When I got COVID-19 in 2020, it didn’t take years for me to get the support and understanding I needed. Even with a (false) negative initial test, no one questioned whether I actually had COVID-19. No one chided me for being lazy. People checked in every day, and the whole world was on pause with me. What a difference that camaraderie made! With COVID-19, I was lonely because I was quarantined, but I never felt alone. With tick-borne illness, I wasn’t lonely because I was around other people, but I often felt alone.

I have learned first-hand that any challenge we face in life is easier with support. If you know someone who has Lyme disease, ask them, “How can I best support you?” Or, ask yourself, “If this friend had cancer or COVID-19, what would I do to support them?” The answer will likely make your friend’s journey a little easier.

Writer

Jennifer Crystal

Opinions expressed by contributors are their own. Jennifer Crystal is a writer and educator in Boston. Her work has appeared in local and national publications including Harvard Health Publishing and The Boston Globe. As a GLA columnist for over six years, her work on GLA.org has received mention in publications such as The New Yorker, weatherchannel.com, CQ Researcher, and ProHealth.com. Jennifer is a patient advocate who has dealt with chronic illness, including Lyme and other tick-borne infections. Her memoir about her medical journey is forthcoming. Contact her via email below.  Email: lymewarriorjennifercrystal@gmail.com

Go here for support groups:

https://danielcameronmd.com/can-lyme-disease-trigger-a-cascade-of-costly-unnecessary-tests/

Can Lyme disease trigger a cascade of costly, unnecessary tests?

Lyme disease patient getting a costly tests including an MRI.
In an article published in JAMA Internal Medicine, Dr. Meredith Niess described a case where routine medical tests triggered a cascade of costly, unnecessary care.

Dr. Meredith Niess discussed the case in more detail in an NPR story.[1] A man was scheduled for hernia surgery. A preoperative X-ray was ordered despite the paucity of evidence of whether the X-ray was needed. The X-ray suggested a mass. The patient was worried about cancer.

Cancer was ruled out. “In fact, a follow-up CT scan showed a clean lung but picked up another suspicious “something” in the patient’s adrenal gland,” stated Neiss. The second CT scan was negative.

Niess used the case “as an example of what researchers call a “cascade of care” — a seemingly unstoppable series of medical tests or procedures.”

This cascade effect has been described before. “With regard to medical technology, the term refers to a chain of events initiated by an unnecessary test, an unexpected result, or patient or physician anxiety, which results in ill-advised tests or treatments that may cause avoidable adverse effects and/or morbidity,” wrote Deyo.[2]

Deyo cited an example of a cascade effect in his review from the professionals who coined the term.

Mold & Stein offered the story of a patient admitted to the hospital for elective repair of an inguinal hernia.[3] “He had a history of coronary disease with very mild arterial narrowing on a previous cardiac catheterization. Anxious about his cardiac status, the surgeons requested a preoperative cardiology consultation. Perhaps uncertain about his own clinical judgment, the cardiologist suggested obtaining an exercise tolerance test.

This was delayed for six hours while the patient waited outside the test room, during which time he became anxious, agitated, and angry, and had some mild chest discomfort. Because of the chest discomfort, the test was not done and the patient was transferred to a telemetry unit. There he became more anxious and agitated, was found to have some electrocardiogram changes, and received medications.

He underwent another cardiac catheterization, which actually showed slight improvement since his previous test. At that point, the hernia repair could not be performed because of a full operating room schedule, and the primary physician was left to try to reassure the patient that he was in no danger. The procedure had to be delayed for two weeks.

In this example, the chain of events seemed to be fueled by physician anxiety, and it snowballed with the addition of patient anxiety.”

Cascade of tests for Lyme disease patients

In some cases, Lyme disease may go undiagnosed and with its broad array of symptoms and presentations can trigger a cascade of costly, unnecessary tests.

Misdiagnosis and delayed diagnosis have been described in a large Lyme disease database.

More than half (51%) reported that it took them more than three years to be diagnosed and roughly the same proportion (54%) saw five or more clinicians before diagnosis. These diagnostic delays occurred despite the fact that 45% of participants reported early symptoms of Lyme disease within days to weeks of exposure,” wrote Johnson et al. [4]

Others with recurrent Lyme disease and Lyme encephalopathy have waited an average of 2 years before receiving treatment.[5,6]

These delays can have life-long repercussions. Once the Borrelia burgdorferi (Bb) infection disseminates, symptoms can become more problematic and treatment more difficult.

References:
  1. When routine medical tests trigger a cascade of costly, unnecessary care. https://www.npr.org/sections/health-shots/2022/06/13/1104141886/cascade-of-care
  2. Deyo RA. Cascade effects of medical technology. Annu Rev Public Health. 2002;23:23-44. doi:10.1146/annurev.publhealth.23.092101.134534
  3. Mold JW, Stein HF. The cascade effect in the clinical care of patients. N Engl J Med. Feb 20 1986;314(8):512-4. doi:10.1056/NEJM198602203140809
  4. Johnson L, Shapiro M, Mankoff J. Removing the Mask of Average Treatment Effects in Chronic Lyme Disease Research Using Big Data and Subgroup Analysis. Healthcare (Basel). Oct 12 2018;6(4)doi:10.3390/healthcare6040124
  5. Fallon BA, Keilp JG, Corbera KM, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. Mar 25 2008;70(13):992-1003. doi:10.1212/01.WNL.0000284604.61160.2d
  6. Cameron DJ. Consequences of treatment delay in Lyme disease. J Eval Clin Pract. Jun 2007;13(3):470-2. doi:10.1111/j.1365-2753.2006.00734.x